
ECCO 2019

Read the full Report (pdf)
European Crohn's and Colitis Organisation
6–9 March 2019, Copenhagen, Denmark
Featured articles


Interview with Prof. Janneke van der Woude
CONTENTS
Online First
New Compounds: Study Results
Selective sphingosine-1-phosphate receptor modulator etrasimod



Short-term and Long-term Treatment Results
The right drug for the right patient
Vedolizumab superior to adalimumab in ulcerative colitis

Ustekinumab as maintenance therapy and with shortened interval
Complementary and Alternative Medicine
Crohn’s disease exclusion diet + partial enteral nutrition in paediatric Crohn’s disease

Microbial composition and psychological wellbeing
Remission

Early remission of Crohn’s disease prevents progression
Proactive adalimumab trough measurements
Observational Studies

The costs and benefits of biologicals
IBD risk of treatment with IL-17 antagonists
Basic and Preclinical Research
